Productos farmacéuticos for Gerencia del Area de Atención Integrada de Guadalajara
Awarded
- Supplies
- Guadalajara, Castilla-La Mancha, España
- 2026/001455
Amount
€3,971,691.16
Tender for Pnsp 27/2026 adquisición de los principios activos laronidase, dupilumab, agalsidasa beta, rasburicasa, sarilumab, cemiplimab, alirocumab, isatuximab y tyrotrofina alfa (sanofi-aventis s.a.) para la gai de guadalajara.
The tender identified with expedient 2026/001455 is related to the sector Supplies.
This tender is located in Guadalajara, Castilla-La Mancha, España, Not specified, Not specified.
The tender is classified under several CPV codes, including CPV, among others Productos farmacéuticos (No code: 33600000), Medicamentos diversos (No code: 33690000), among others.
All information updated in real time
Award criteria
Location:
Guadalajara, Castilla-La Mancha, EspañaStatus
AwardedProcedure
Negotiated without publicationContract type
SuppliesPublication date
-Budget excluding taxes
€3,971,691.16Estimated contract value
€3,971,691.16Deadline
-Contract duration
-Extension
-Guarantee
-
View complete and updated information
To access all detailed and updated information about this tender, access our Tendios platform.
Access Tendios